Suppr超能文献

7-(2-氨基乙基)-3,4-二氢-5-羟基-2H-1,4-苯并噻嗪-3-羧酸(DHBT-1)对线粒体复合物I的不可逆抑制作用:一种与帕金森病相关的推测性黑质内毒素。

Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.

作者信息

Li H, Dryhurst G

机构信息

Department of Chemistry and Biochemistry, University of Oklahoma, Norman 73019, U.S.A.

出版信息

J Neurochem. 1997 Oct;69(4):1530-41. doi: 10.1046/j.1471-4159.1997.69041530.x.

Abstract

Based on a number of lines of evidence, we have proposed recently that a very early step in the pathogenesis of idiopathic Parkinson's disease might be elevated translocation of L-cysteine into neuromelanin-pigmented dopaminergic cell bodies in the substantia nigra. In vitro studies suggest that such an influx of L-cysteine would divert the neuromelanin pathway by scavenging dopamine-o-quinone, the proximate autoxidation product of dopamine, to give 5-S-cysteinyldopamine, which is oxidized further to 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1) and other cysteinyldopamines and dihydrobenzothiazines. In this study, it is demonstrated that DHBT-1 inhibits ADP-stimulated oxidation of malate and pyruvate (state 3 or complex I respiration) when incubated with intact rat brain mitochondria with an IC50 of approximatelly 0.80 mM. Incubation of DHBT-1 with freeze-thawed rat brain mitochondria in both the presence and absence of KCN and/or NADH causes an irreversible, time-dependent decrease of NADH-coenzyme Q1 reductase activity. Significantly lower concentrations of DHBT-1 are necessary to cause this effect when mitochondrial membranes are incubated in the absence of KCN and NADH. The irreversible inhibition of mitochondrial complex I caused by DHBT-1 under the latter conditions could be blocked only partially by glutathione, ascorbic acid, superoxide dismutase, or catalase. Together, these results suggest that DHBT-1 can cross the outer mitochondrial membrane and irreversibly inhibit complex I by a mechanism that is not primarily related to oxygen radical-mediated damage. Formation of DHBT-1 requires only dopamine, L-cysteine, and an oxidizing environment, conditions that may well exist in the cytoplasm of neuromelanin-pigmented dopaminergic neurons in the parkinsonian substantia nigra. The results of this study raise the possibility that DHBT-1 might be an endotoxin formed specifically in pigmented dopaminergic neurons that can contribute to irreversible damage to mitochondrial complex I and substantia nigra cell death in Parkinson's disease.

摘要

基于一系列证据,我们最近提出,特发性帕金森病发病机制中一个非常早期的步骤可能是L-半胱氨酸向黑质中神经黑色素沉着的多巴胺能细胞体的转运增加。体外研究表明,这种L-半胱氨酸的流入会通过清除多巴胺的直接自氧化产物多巴胺邻醌来改变神经黑色素途径,生成5-S-半胱氨酰多巴胺,其进一步氧化为7-(2-氨基乙基)-3,4-二氢-5-羟基-2H-1,4-苯并噻嗪-3-羧酸(DHBT-1)以及其他半胱氨酰多巴胺和二氢苯并噻嗪。在本研究中,已证明当与完整的大鼠脑线粒体一起孵育时,DHBT-1会抑制ADP刺激的苹果酸和丙酮酸氧化(状态3或复合体I呼吸),IC50约为0.80 mM。在有和没有KCN和/或NADH的情况下,将DHBT-1与冻融的大鼠脑线粒体一起孵育会导致NADH-辅酶Q1还原酶活性出现不可逆的、时间依赖性的降低。当在没有KCN和NADH的情况下孵育线粒体膜时,导致这种效应所需的DHBT-1浓度显著更低。在后者条件下,DHBT-1对线粒体复合体I的不可逆抑制仅能被谷胱甘肽、抗坏血酸、超氧化物歧化酶或过氧化氢酶部分阻断。总之,这些结果表明,DHBT-1可以穿过线粒体外膜,并通过一种并非主要与氧自由基介导的损伤相关的机制不可逆地抑制复合体I。DHBT-1的形成仅需要多巴胺、L-半胱氨酸和一个氧化环境,而这些条件很可能存在于帕金森病患者黑质中神经黑色素沉着的多巴胺能神经元的细胞质中。本研究结果提出了一种可能性,即DHBT-1可能是一种专门在色素沉着的多巴胺能神经元中形成的内毒素,它可能导致帕金森病中线粒体复合体I的不可逆损伤和黑质细胞死亡。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验